BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 33408772)

  • 1. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
    Sun SJ; Lai WH; Jiang Y; Zhen Z; Wei R; Lian Q; Liao SY; Tse HF
    Theranostics; 2021; 11(4):1641-1654. PubMed ID: 33408772
    [No Abstract]   [Full Text] [Related]  

  • 2. Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure.
    Liao S; Zhang Y; Ting S; Zhen Z; Luo F; Zhu Z; Jiang Y; Sun S; Lai WH; Lian Q; Tse HF
    Stem Cell Res Ther; 2019 Mar; 10(1):78. PubMed ID: 30845990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
    Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
    Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
    Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
    Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of Multiple Biological Therapies for Ischemic Cardiac Disease.
    Winters AA; Bou-Ghannam S; Thorp H; Hawayek JA; Atkinson DL; Bartlett CE; Silva FJ; Hsu EW; Moreno AP; Grainger DA; Patel AN
    Cell Transplant; 2016; 25(9):1591-1607. PubMed ID: 27165370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.
    Luger D; Lipinski MJ; Westman PC; Glover DK; Dimastromatteo J; Frias JC; Albelda MT; Sikora S; Kharazi A; Vertelov G; Waksman R; Epstein SE
    Circ Res; 2017 May; 120(10):1598-1613. PubMed ID: 28232595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial repair of bioengineered cardiac patches with decellularized placental scaffold and human-induced pluripotent stem cells in a rat model of myocardial infarction.
    Jiang Y; Sun SJ; Zhen Z; Wei R; Zhang N; Liao SY; Tse HF
    Stem Cell Res Ther; 2021 Jan; 12(1):13. PubMed ID: 33413626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.
    Huang B; Qian J; Ma J; Huang Z; Shen Y; Chen X; Sun A; Ge J; Chen H
    Stem Cell Res Ther; 2014 Feb; 5(1):22. PubMed ID: 24507665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated intravenous administration of hiPSC-MSCs enhance the efficacy of cell-based therapy in tissue regeneration.
    Sun SJ; Li F; Dong M; Liang WH; Lai WH; Ho WI; Wei R; Huang Y; Liao SY; Tse HF
    Commun Biol; 2022 Aug; 5(1):867. PubMed ID: 36008710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice.
    Zhao M; Fan C; Ernst PJ; Tang Y; Zhu H; Mattapally S; Oduk Y; Borovjagin AV; Zhou L; Zhang J; Zhu W
    Cardiovasc Res; 2019 Feb; 115(2):343-356. PubMed ID: 30107391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice.
    Fan C; Tang Y; Zhao M; Lou X; Pretorius D; Menasche P; Zhu W; Zhang J
    J Mol Cell Cardiol; 2020 Apr; 141():1-10. PubMed ID: 32169551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo.
    Haneef K; Ali A; Khan I; Naeem N; Jamall S; Salim A
    Cardiovasc Ther; 2018 Dec; 36(6):e12479. PubMed ID: 30451388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance.
    Huang P; Wang L; Li Q; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Liu J; Qian L; Yang Y
    Stem Cell Res Ther; 2019 Oct; 10(1):300. PubMed ID: 31601262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.
    Shen H; Cui G; Li Y; Ye W; Sun Y; Zhang Z; Li J; Xu G; Zeng X; Zhang Y; Zhang W; Huang Z; Chen W; Shen Z
    Stem Cell Res Ther; 2019 Jan; 10(1):17. PubMed ID: 30635025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.
    Lu D; Liao Y; Zhu SH; Chen QC; Xie DM; Liao JJ; Feng X; Jiang MH; He W
    Stem Cell Res Ther; 2019 Apr; 10(1):127. PubMed ID: 31029167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1q/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction.
    Zhang Z; Zhu L; Feng P; Tan Y; Zhang B; Gao E; Wang X; Fan C; Wang X; Yi W; Sun Y
    Cell Death Dis; 2019 Jul; 10(7):530. PubMed ID: 31296837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
    Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
    Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
    Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice.
    Mattapally S; Zhu W; Fast VG; Gao L; Worley C; Kannappan R; Borovjagin AV; Zhang J
    Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H327-H339. PubMed ID: 29631371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.